Clinical and Laboratory Study on Late-Onset Urea Cycle Defects

杨艳玲,常俊霞,袁云,张月华,钱宁,宋金青,秦炯
DOI: https://doi.org/10.3760/j.issn:1006-7876.2004.02.016
2004-01-01
Abstract:Objective To study the clinical and laboratory findings of the patients with late-onset urea cycle defects (UCD). Methods Two males and two females with hyperammonemia due to UCD were confirmed by blood and urine amino acids analysis and urinary organic acid analysis with gas chromatography-mass spectrometry (GC-MS). Their clinical features, laboratory findings, diagnosis, treatment and outcome were reviewed. Results The onset of hyperammonemic encephalopathy occurred at the age of 30, 63, 13 and 29 years in the 4 patients. Three patients had positive family history. Case 1 exhibited progressive lethargy, vomiting and seizures after her second delivery, and died at the 8th day. Case 2 had progressive memory deterioration for 2 years and spastic paraplegia for 1 month. Case 3 developed headaches, lethargy, movement disorder and seizures after medication of paracetamol, and died 23 days after. Case 4 presented with abnormal liver function, recurrent lethargy for 8 months and progressive spastic paraplegia for 2 months. All of them had severe hyperammonemia and varied liver dysfunction. Ornithine transcarbamylase (OTC) deficiency was found in case 1 and 2. Citrulinemia type Ⅰ and type Ⅱ was detected in case 3 and 4, respectively. In case 4, 851del4/1638ins23 mutations in SLC25A13 gene was confirmed. Case 1 and 3 died before diagnosis. Case 2 and 4 were treated by protein-restricted diet, arginine and carnitine supplementation. Significant clinical and biochemical improvement was observed, but motor handicap of legs remained. Conclusions UCD are the most frequent causes of hyperammonemia. Four patients with late-onset UCD were detected. All of them had progressive encephalopathy and liver dysfunction. Two died and 2 remained motor deficits because of the delayed diagnosis. Early diagnosis and adequate treatment are the key points to improve the prognosis of the patients. Blood ammonia assay should be considered in the differential diagnosis of acute or chronic encephalopathy at any age.
What problem does this paper attempt to address?